All In MedTech

Device Trial Radar · NCT02617706

Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Colon Surgery

A Prospective, Randomized, Parallel Study Comparing Transdermal, Continuous Oxygen Delivery to Standard of Care to Assess Postoperative Wound Infection Rate in Colon and Rectal Resections

Last checked: Nov 20, 2026Latest source record: Aug 14, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Jan 2017

Primary completion

Jan 2018

Study completion Jan 2019

Sponsor

Lead sponsor
Neogenix, LLC dba OgenixNot on our public-company list
Sponsor type
Industry
First posted
Dec 1, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

EPIFLO® unit along with standard wound care vs only standard wound care for Surgical site infections (SSI).

Conditions

  • Anorectal Surgeries

Interventions

  • EpifloDevice

    Transdermal continuous oxygen therapy is oxygen delivery to the wound site directly. Ogenix makes a small portable oxygen concentrator (Trade Name: EPIFLO) that makes continuous transdermal delivery of oxygen possible. It is a 3 ounce oxygen generator that continuously delivers 3 ml of pure oxygen to the wound site.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of patients with surgical site infections measured with the Southampton Scoring System. The number of subjects with infection of the surgical site will be compared using chi-square or Fisher Exact test.Time frame: 30 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Department of General Surgery Allegheny General Hospital

    Pittsburgh, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.